Faced with increasing rates of opioid addiction and insufficient treatment capacity to meet demand for care, Vermont developed a novel framework to expand medication assisted treatment in both Opioid Treatment Programs (OTPs) and Office-Based Opioid Treatment (OBOT) settings. Although this initiative initially focuses on medication assisted treatment for individuals with opiate addictions, it creates a framework for integrating treatment services for other substance abuse issues and co-occurring mental health disorders into the medical home through a managed approach to care. In addition, this treatment approach will help reduce recidivism in corrections and enhance outcomes for families where addiction is an identified problem for child welfare.
This Webinar will review:
- the staffing and services framework,
- use of the Health Home opportunity for addictions care in the Affordable Care Act,
- key strategies to improve the quality of care, and
- experiences in integrating health and addictions care for individuals with opioid addiction.
No Pricing information available
At the conclusion of the session, participants will be able to:
- Identify specific strategies to expand access to Medication Assisted Treatment. These strategies include enhanced staffing and expanded program offerings in OTP and OBOT settings. These strategies were developed to systematically address common barriers to the provision of MAT services.
- Describe how “Health Homes” authorized under section 2703 of the Affordable Care Act can be used for addictions treatment.
- Identify measurement tools for key aspects of evidenced based MAT services to help improve quality.
Physicians who have a waiver to treat opioid use disorder in an office-based setting and other interested clinicians.
Estimated Time to Complete
- Estimated Duration: 1 Hour
- Start Date: February 9, 2016
- End Date: February 23, 2016
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course. A multiple choice quiz is provided based on the content. A passing score of 60% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the date of completion and hours earned.
Continuing Education Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
- Beth Tanzman, MSW, Assistant Director, Vermont Blueprint for Health, Dept of Vermont Health Access, Vermont Department of Health. Reports no financial relationships with commercial interests.
- Anthony Folland, Clinical Services Manager, VT State Opiate Treatment Authority, Division of Alcohol & Drug Abuse Programs. Reports no financial relationships with commercial interests.
- Adam Bisaga, Professor of Psychiatry, Columbia University Medical Center. Disclosure: Alkermes: Clinical Trial site PI.
- Andrew Saxon, M.D., Professor, Department of Psychiatry & Behavioral Sciences; Director, Addiction Psychiatry Residency Program, University of Washington; Director, Center of Excellence in Substance Abuse Treatment and Education (CESATE) VA Puget Sound Health Care System. Reports no financial relationships with commercial interests.
- Beatrice Eld, Deputy Director of Education for Addiction Psychiatry, American Psychiatric Association. Reports no financial relationships with commercial interests
- Frances R. Levin, M.D., Kennedy Leavy Professor of Psychiatry at Columbia University Medical Center; Director, Addiction Psychiatry Fellowship, New York Presbyterian Hospital; Director of Clinical and Educational Activities for the Division on Substance Abuse, New York State Psychiatric Institute. Disclosure: Consultant: Major League Baseball, Grant/Research Support: US World Med.
- John A. Renner, Jr., M.D., Professor of Psychiatry, Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact email@example.com questions about this course | Contact firstname.lastname@example.org for technical assistance